Also known as: body high · body buzz · stone · couch-lock high

Physical High

Slang for the bodily, sedating side of a cannabis experience — heavy limbs, couch-lock, tingling — as opposed to the head-focused effects.

Sourced and fact-checked
9 cited sources
Published 1 hour ago
How this page was made
↯ The honest take

"Physical high" is useful slang, not a pharmacological category. It describes a real subjective pattern — heaviness, relaxation, sedation, sometimes tingling — but the popular story that this comes from indica genetics or from CBD or CBN is mostly folklore. Dose, tolerance, terpene profile, set and setting, and route of administration all shape whether an experience feels bodily or heady. Treat the term as descriptive vocabulary, not as a prediction you can make from a strain name on a jar.

Definition

A physical high (or body high) is the subjective experience where cannabis effects feel concentrated in the body rather than the mind. Typical descriptors include heavy limbs, muscle relaxation, warmth or tingling, appetite, drowsiness, and reduced motivation to move — the classic "couch-lock." It is a folk term used by consumers, budtenders, and marketing copy, not a defined clinical endpoint. There is no lab test that distinguishes a "body" from a "head" high; the label describes what a person reports feeling.

What actually causes it

The primary driver of any cannabis high — bodily or cerebral — is THC acting at CB1 receptors, which are densely expressed in the central nervous system [1][2]. CB1 activation in areas like the basal ganglia and cerebellum plausibly contributes to the motor slowing and heaviness people call a body high, while activation in cortical and limbic regions contributes to cognitive and mood effects [1]. In practice, whether a given session skews "physical" depends on:

What it probably isn't

Several popular explanations are weaker than they sound:

How the term is used

You'll see "physical high" in three main contexts:

  1. Consumer reviews describing a specific batch or session ("a heavy body high, great for after work").
  2. Dispensary and marketing copy pitching a product's intended effect, often paired with an indica label — treat this as vibes-based recommendation, not a specification.
  3. Medical discussion where patients distinguish desired bodily effects (pain relief, muscle relaxation, sleep onset) from unwanted cognitive impairment. This usage is legitimate but still subjective.

When writing or reading about cannabis, it's more precise to say what you actually mean: sedating, muscle-relaxing, appetite-stimulating, motor-slowing. Those are effects that can be measured. "Body high" bundles them together into a mood.

See also

Related terms: Head High, Couch-Lock, Cerebral High, Entourage Effect, Indica vs Sativa.

Sources

  1. Peer-reviewed Mackie K. (2008). Cannabinoid receptors: where they are and what they do. Journal of Neuroendocrinology, 20 Suppl 1, 10-14.
  2. Peer-reviewed Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199-215.
  3. Peer-reviewed Ramaekers JG, Kauert G, Theunissen EL, et al. (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology, 23(3), 266-277.
  4. Peer-reviewed Lemberger L, Weiss JL, Watanabe AM, et al. (1972). 11-hydroxy-delta9-tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Science, 177(4043), 62-64.
  5. Peer-reviewed Kirk JM, de Wit H. (1999). Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacology Biochemistry and Behavior, 63(1), 137-142.
  6. Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
  7. Peer-reviewed Piomelli D, Russo EB. (2016). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44-46.
  8. Peer-reviewed Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE. (1975). Effects of delta9-tetrahydrocannabinol and cannabinol in man. Pharmacology, 13(6), 502-512.
  9. Peer-reviewed Solowij N, Broyd S, Greenwood LM, et al. (2019). A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 17-35.

How this page was made

Generation history

Jul 15, 2026
Fact-check pass — raised 2 flags
Jul 15, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.